Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris

Archives of Dermatology

Volumn 144, Issue 5, 2008, Pages 654-657

  Saggar, Sarika ^a   Zeichner, Joshua A ^b   Brown, Tamu T ^a   Phelps, Robert G ^b   Cohen, Steven R ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; LIQUID NITROGEN; METHOTREXATE; PREDNISONE; RAPAMYCIN; RITUXIMAB; THIOMALATE SODIUM; TRIAMCINOLONE;

ADULT; ARTICLE; CASE REPORT; CRYOSURGERY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LOW DRUG DOSE; MALE; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REMISSION; SKIN BIOPSY; TREATMENT OUTCOME; TREATMENT RESPONSE;

HUMANS; IATROGENIC DISEASE; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PEMPHIGUS; RETREATMENT; SARCOMA, KAPOSI; SIROLIMUS; SKIN NEOPLASMS;

EID: 44249117090     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.5.654     Document Type: Article

References (20)

1. Trattner A, Hodak E, David M, Sandbank M. The appearance of Kaposi sarcoma during corticosteroid therapy. Cancer. 1993;72(5):1779-1783.
2. Cathomas G, Tamm M, McGandy C, et al. Transplantation-associated malignancies. Transplantation. 1997;64(1):175-178.
3. Avalos-Peralta P, Herrera A, Ríos-Martín JJ, Pérez-Bernal AM, Moreno-Ramírez D, Camacho F. Localized Kaposi's sarcoma in a patient with pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2006;20(1):79-83.
4. Kolhe N, Mamode N, Van der Walt J, Pattison J. Regression of post-transplant Kaposi's sarcoma using sirolimus. Int J Clin Pract. 2006;60(11):1509-1512.
5. Gutiérrez-Dalmau A, Sánchez-Fructuoso A, Sanz-Guajardo A, et al. Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma. Transplant Proc. 2005;37(9):3836-3838.
6. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med. 2005;352(13):1317-1323.
7. Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syph (Prague). 1872;4:265-273.
8. Geraminejad P, Memar O, Aronson I, Rady PL, Hengge U, Tyring SK. Kaposi's sarcoma and other manifestations of human herpesvirus 8. J Am Acad Dermatol. 2002;47(5):641-655.
9. Kirova YM, Belembaogo E, Frikha H, Yu SJ, Le Bourgeois JP. Kaposi sarcoma. Cancer Radiother. 1997;1(4):277-282.
10. Serraino D, Angeletti C, Carrieri MP, et al. Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation. 2005;80(12):1699-1704.
11. Wasywich CA, Croxson MC, van Doornum GJ, Coverdale HA, Ruygrok PN. Sirolimus for Kaposi's sarcoma. J Heart Lung Transplant. 2006;25(6):726-729.
12. Zmonarski SC, Boratynska M, Puziewicz-Zmonarska A, Kazimierczak K, Klinger M. Kaposi's sarcoma in renal transplant recipients. Ann Transplant. 2005;10(2):59-65.
13. Stanley JR. Therapy of pemphigus vulgaris. Arch Dermatol. 1999;135(1):76-78.
14. Dick SE, Werth VP. Pemphigus: a treatment update. Autoimmunity. 2006;39(7):591-599.
15. Alkan S, Karcher D, Ortiz A, Khalil S, Akhtar M, Ali MA. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus in organ transplant patients with immunosuppression. Br J Haematol. 1997;96(2):412-414.
16. Campistol JM, Eris J, Oberbauer R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol. 2006;17(2):581-589.
17. Rapamune prescribing information. Wyeth Website. http://us.rapamune.com/. Accessed September 14, 2006.
18. Chan S. Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer. Br J Cancer. 2004;91(8):1420-1424.
19. Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis involvement of vascular endothelial growth factor. Nat Med. 2002;8(2):128-135.
20. Mahé E, Morelon E, Lechaton S, et al. Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation. 2005;79(4):476-482.